X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15506) 15506
Book Review (1056) 1056
Publication (789) 789
Book Chapter (79) 79
Newsletter (60) 60
Newspaper Article (33) 33
Conference Proceeding (23) 23
Magazine Article (15) 15
Book / eBook (7) 7
Dissertation (5) 5
Reference (4) 4
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14505) 14505
humans (9725) 9725
animals (6660) 6660
adenosine diphosphate - pharmacology (5592) 5592
male (5553) 5553
platelet aggregation - drug effects (3991) 3991
female (3770) 3770
blood platelets - drug effects (2640) 2640
rats (2568) 2568
adult (2403) 2403
adenosine diphosphate - metabolism (2218) 2218
blood platelets - metabolism (2149) 2149
middle aged (2137) 2137
in vitro techniques (1755) 1755
hematology (1713) 1713
platelet aggregation (1655) 1655
abridged index medicus (1629) 1629
collagen - pharmacology (1579) 1579
biochemistry & molecular biology (1503) 1503
adenosine triphosphate - metabolism (1465) 1465
adenosine diphosphate (1438) 1438
aged (1366) 1366
kinetics (1311) 1311
time factors (1285) 1285
mice (1245) 1245
blood platelets - physiology (1235) 1235
pharmacology & pharmacy (1101) 1101
peripheral vascular disease (1095) 1095
epinephrine - pharmacology (1084) 1084
platelets (1053) 1053
dose-response relationship, drug (1041) 1041
platelet aggregation inhibitors - pharmacology (1022) 1022
thrombin - pharmacology (982) 982
aggregation (974) 974
cell biology (941) 941
activation (929) 929
rabbits (890) 890
adp (734) 734
adenosine diphosphate - blood (730) 730
research (695) 695
blood platelets (690) 690
physiology (677) 677
physiological aspects (655) 655
metabolism (633) 633
analysis (616) 616
aspirin - pharmacology (608) 608
platelet activation - drug effects (600) 600
platelet adhesiveness - drug effects (597) 597
inhibition (591) 591
cardiac & cardiovascular systems (589) 589
cells, cultured (588) 588
proteins (585) 585
phosphorylation (574) 574
aspirin (560) 560
calcium - metabolism (549) 549
enzymes (542) 542
adenosine triphosphate - blood (532) 532
clopidogrel (527) 527
adenosine monophosphate - metabolism (524) 524
cells (514) 514
rats, wistar (514) 514
hydrogen-ion concentration (513) 513
dogs (506) 506
expression (506) 506
ticlopidine - analogs & derivatives (506) 506
collagen (504) 504
adolescent (502) 502
thrombosis (488) 488
rats, sprague-dawley (481) 481
adenosine triphosphate - pharmacology (480) 480
blood (473) 473
neurosciences (464) 464
atp (462) 462
adenosine (458) 458
flow cytometry (448) 448
thrombin (448) 448
arachidonic acid (445) 445
adenosine-diphosphate (429) 429
diphosphates (427) 427
signal transduction (427) 427
platelet aggregation - physiology (419) 419
medicine, research & experimental (418) 418
article (416) 416
oncology (406) 406
fibrinogen - metabolism (399) 399
disease models, animal (393) 393
biophysics (392) 392
rats, inbred strains (388) 388
platelet aggregation inhibitors - therapeutic use (386) 386
blood platelets - cytology (384) 384
blood platelets - ultrastructure (382) 382
molecular sequence data (379) 379
platelet function tests (379) 379
platelet count (375) 375
platelet adhesiveness (370) 370
adenosine triphosphatase (368) 368
energy metabolism (367) 367
platelet activation (366) 366
receptor (357) 357
blood platelets - enzymology (352) 352
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14800) 14800
Russian (371) 371
German (135) 135
French (100) 100
Japanese (73) 73
Italian (50) 50
Chinese (47) 47
Polish (28) 28
Spanish (27) 27
Ukrainian (7) 7
Bulgarian (6) 6
Czech (5) 5
Danish (5) 5
Croatian (3) 3
Norwegian (3) 3
Slovak (3) 3
Portuguese (2) 2
Dutch (1) 1
Hungarian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 12/2017, Volume 179, Issue 5, pp. 802 - 810
Journal Article
Circulation Research, ISSN 0009-7330, 03/2015, Volume 116, Issue 7, pp. 1206 - 1215
RATIONALE:Purinergic signaling plays an important role in inflammation and vascular integrity, but little is known about purinergic mechanisms during the... 
adenosine | atherosclerosis | thrombosis | adenosine diphosphate | adenosine triphosphate | smoking | receptors, purinergic P1 | NUCLEOTIDE-METABOLISM | CD73 | CARDIAC & CARDIOVASCULAR SYSTEMS | ADP | ENDOTHELIAL-CELLS | DISEASE | VASCULAR INFLAMMATION | CD39 | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | E-DEFICIENT MICE | Smoking - adverse effects | Age Factors | Humans | Middle Aged | Hypertension - drug therapy | Male | Adenosine Triphosphate - blood | Apyrase - blood | Thrombophilia - epidemiology | Atherosclerosis - epidemiology | Drug Utilization | Thrombophilia - etiology | 5'-Nucleotidase - blood | Adenosine Diphosphate - blood | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Peripheral Arterial Disease - blood | Aged, 80 and over | Adult | Female | Hypertension - epidemiology | Alkaline Phosphatase - blood | Purinergic P2Y Receptor Antagonists - therapeutic use | Second Messenger Systems | Smoking - blood | Comorbidity | Models, Cardiovascular | Risk Factors | Disease Progression | Atherosclerosis - blood | Artifacts | Antigens, CD - blood | Hypoxia - blood | Thrombophilia - blood | Peripheral Arterial Disease - epidemiology | Smoking - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Biomarkers | GPI-Linked Proteins - blood | Aged | Chronic Disease | Finland - epidemiology | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2018, Volume 13, Issue 5, pp. e0196478 - e0196478
Background The development of thrombocytopenia in sepsis is a poor prognostic indicator associated with a significantly increased mortality risk. Mechanisms... 
RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | NITRIC-OXIDE | MATRIX-METALLOPROTEINASE-9 | RELEASE | INHIBITORS | THROMBOPOIETIN | EXPRESSION | ACTIVATED PLATELETS | SEVERITY | Blood Platelets - pathology | Leukocytes - pathology | Shock, Septic - pathology | Humans | Middle Aged | Platelet Activation - physiology | Male | Blood Platelets - enzymology | Thrombocytopenia - pathology | Leukocytes - enzymology | Case-Control Studies | Thrombocytopenia - blood | Matrix Metalloproteinase 2 - blood | Thrombocytopenia - enzymology | Platelet Count | Toll-Like Receptor 4 - blood | Blood Platelets - metabolism | Shock, Septic - blood | Female | Shock, Septic - enzymology | Leukocytes - metabolism | Matrix Metalloproteinase 9 - blood | Thrombocytopenia | Complications and side effects | Blood platelets | Physiological aspects | Development and progression | Sepsis | Activation | Metalloproteins | Health aspects | TLR4 | Risk factors | Flow cytometry | Intensive care | Matrix metalloproteinases | Critical care | Proteins | Ethics | Gelatin | Toll-like receptors | Enzyme-linked immunosorbent assay | Pharmaceutical sciences | Adenosine diphosphate | Septic shock | Pharmacology | TLR4 protein | Patients | Thrombosis | Phospholipase A | Gelatinase B | Gelatinase A | White blood cells | Immune systems | Medicine | Cytometry | Hospitals | Pharmacy | Platelets | Index Medicus
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 03/2013, Volume 62, Issue 3, pp. 260 - 266
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2011, Volume 31, Issue 7, pp. 1607 - 1616
OBJECTIVE—Hypothermia is used in various clinical settings to inhibit ischemia-related organ damage. However, prothrombotic effects have been described as... 
CD39 | platelet receptor blockers | hypothermia | ADP | platelets | SURGERY | THROMBUS FORMATION | HOSPITAL CARDIAC-ARREST | CARDIOPULMONARY BYPASS | INHIBITION | ADENINE-NUCLEOTIDES | ALPHA-GRANULE RELEASE | HUMAN-BLOOD | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CIRCULATORY ARREST | AGGREGATION | Humans | Receptors, Purinergic P2Y12 - drug effects | Receptors, Purinergic P2Y1 - drug effects | Receptors, Purinergic P2Y1 - blood | Apyrase - blood | Adenosine Diphosphate - blood | Leukopenia - blood | Receptors, Purinergic P2Y12 - blood | Apyrase - pharmacology | Platelet Aggregation Inhibitors - pharmacology | Thrombosis - blood | Thrombosis - prevention & control | Blood Platelets - drug effects | von Willebrand Factor - metabolism | Purinergic P2Y Receptor Antagonists - pharmacology | Hypothermia, Induced - adverse effects | Thrombocytopenia - etiology | Mice, Inbred C57BL | Membrane Glycoproteins - blood | Recombinant Proteins - pharmacology | Thrombocytopenia - blood | Platelet Adhesiveness - drug effects | Hydrolysis | Fibrinolytic Agents - pharmacology | Antigens, CD - blood | Animals | Analysis of Variance | Blood Platelets - metabolism | Thrombosis - etiology | Fibrinogen - metabolism | P-Selectin - blood | Antigens, CD - pharmacology | Mice | Platelet Activation - drug effects | Platelet Glycoprotein GPIb-IX Complex | Leukopenia - etiology | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2009, Volume 113, Issue 12, pp. 2835 - 2842
Clinical trials with antiangiogenic agents have not been able to validate plasma or serum levels of angiogenesis regulators as reliable markers of cancer... 
FACTOR VEGF | HUMAN MEGAKARYOCYTES | PROTEIN | ALPHA-GRANULES | PROSTATE-CANCER | TUMOR ANGIOGENESIS | HUMAN LIPOSARCOMA | RELEASE | HEMATOLOGY | ENDOTHELIAL GROWTH-FACTOR | ENDOSTATIN | Neoplasm Transplantation | Humans | Liposarcoma - blood supply | Fibroblast Growth Factor 2 - pharmacology | Drug Implants | Male | Cell Line, Tumor - transplantation | Liposarcoma - secretion | Neovascularization, Pathologic - blood | Vascular Endothelial Growth Factor A - secretion | Fibroblast Growth Factor 2 - secretion | Laminin | Thrombin - pharmacology | Neoplasm Proteins - secretion | Platelet-Derived Growth Factor - analysis | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Vascular Endothelial Growth Factor A - administration & dosage | Vascular Endothelial Growth Factor A - pharmacology | Vascular Endothelial Growth Factor A - pharmacokinetics | Liposarcoma - blood | Proteoglycans | Liposarcoma - pathology | Mice, Inbred C57BL | Vascular Endothelial Growth Factor A - blood | Fibroblast Growth Factor 2 - blood | Mice, SCID | Adenosine Diphosphate - pharmacology | Animals | Angiogenic Proteins - blood | Blood Platelets - metabolism | Collagen | Proteomics | Endostatins - blood | Neoplasm Proteins - blood | Mice | Platelet Activation - drug effects | Drug Combinations | Index Medicus | Abridged Index Medicus | Platelets and Thrombopoiesis
Journal Article
Advances in experimental medicine and biology, ISSN 0065-2598, 2017, Volume 906, p. 307
Journal Article
Renal Failure, ISSN 0886-022X, 5/2014, Volume 36, Issue 4, pp. 613 - 618
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 16, pp. 1541 - 1547
Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease Dominick J. Angiolillo, Esther... 
Cardiovascular | Internal Medicine | VARIABILITY | CLOPIDOGREL TREATMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | INCREASED RISK | LOW-RESPONDERS | ACUTE MYOCARDIAL-INFARCTION | ASPIRIN | INTERVENTION | ANTIPLATELET THERAPY | AGGREGATION | Multivariate Analysis | Myocardial Infarction - blood | Predictive Value of Tests | Prognosis | Prospective Studies | Follow-Up Studies | Outcome Assessment (Health Care) | Ticlopidine - therapeutic use | Humans | Platelet Activation - physiology | Male | Blood Platelets - physiology | Coronary Artery Disease - blood | Death, Sudden, Cardiac | Stroke - physiopathology | Sensitivity and Specificity | Female | Myocardial Infarction - physiopathology | Renal Insufficiency - complications | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation - physiology | Coronary Artery Disease - drug therapy | Ticlopidine - analogs & derivatives | Stroke - blood | Diabetes Mellitus, Type 2 - blood | Angina, Unstable - blood | Angina, Unstable - physiopathology | ROC Curve | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Care and treatment | Blood sugar monitoring | Cardiac patients | Patient outcomes | Adenosine diphosphate | Coronary heart disease | Insulin | Plasma | Aspirin | Heart attacks | Blood platelets | Coronary vessels | Cardiovascular disease | Diabetes | Drug therapy | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2015, Volume 13, Issue 10, pp. 1878 - 1887
Journal Article